Discure Technologies Accepted into FDA TAP Program for Its Breakthrough Device for Degenerative Disc Disease Discure Technologies, developing a bioelectronic implant for degenerative disc disease, a leading cause of back pain, is accepted into FDA's TAP Program.

With Tennis Season Approaching, ZetrOZ Systems' Multi-Hour sam® Sport Treatment Helps Athletes with Elbow Pain and Recovery TRUMBULL, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- When tennis season begins, many professional and collegiate players will turn to pain medication for relief from lateral epicondylitis,...